Introduction
C ardiovascular diseases (CVD) is the cause of 30% of all deaths in 2010. 1 Cardiac rehabilitation (CR) has documented a 20% reduction in all-cause mortality and a 27% reduction in cardiac mortality in systematic reviews. 2, 3 A CR program is defined as a secondary preventive program that includes interventions such as exercise and patient education on risk factors in order to achieve and maintain a healthy lifestyle. 4 Globally, low participation rates for patients in CR programs have been reported. 5 Cardiac telerehabilitation (CTR) is defined as CR using information and communication technology. CTR appears to be an effective strategy to increase both patients' attendance in CR and longterm adherence to recommendations, as well as being in particular a promising new tool to include patients who are not able to attend such a program for various reasons. 6, 7 However, there is a lack of multidisciplinary evaluations of CTR programs, including health economic studies. 6 This study conducted a cost-utility (CU) analysis (CUA) of the Teledialog research project. The aim of the project was to develop and test an individualized CTR program designed to increase participation in rehabilitation, improve patient quality of life, reduce the number of admissions, and reduce the need for acute care. As part of the Teledialog project, a CTR program was developed and tested in a randomized controlled trial of cardiac patients diagnosed with artery sclerosis, coronary artery bypass surgery, valve surgery, and heart failure.
Materials and Methods

THE INTERVENTION
A CTR program was developed and tested in 2012-2014 in a randomized controlled trial (n = 151). Two hospitals, four municipal healthcare centers, and a call center took part in the program. On being discharged from hospital, the cardiac patients were enrolled by a project nurse, who included the patients based on various inclusion and exclusion criteria ( Table 1 ).
The project nurse performed an interview with each patient and identified the patient's need for rehabilitation and the place where rehabilitation would be carried out (hospital, healthcare center, or call center). The important part of the CTR was to design an individual rehabilitation based on the patient's needs.
The patient was registered as a user in the information technology platforms and was equipped with a tablet computer giving him or her Web access to his or her own personal health record and measurements. The patient received training in the use of the different devices and the digital rehabilitation plan, and a doctor prescribed how often the patient needed to measure blood pressure, pulse, and weight, most often twice a week, whereas steps were measured every day. The data were transmitted via a secure transmission line. Patients, relatives, and healthcare professionals from the hospital and healthcare centers were able to communicate and share data from the personal health record. In addition, patients and relatives had access to Activeheart.dk (a digital toolbox with information on rehabilitation topics, activities, and videos showing patients describing their experiences of being a heart patient and appropriate exercises for after surgery).
After 2 weeks in the program, each patient was visited by a project assistant in order to make sure that the patient and relative were confident in using the technology. Healthcare professionals monitored the measured values every week, contacted the patients if the values were abnormal, and discussed rehabilitation activities with the patient. The telerehabilitation program lasted for 3 months. Table 2 gives further description of the equipment.
The control group followed a traditional rehabilitation program at the hospital or healthcare center based on CR guidelines. Aalborg University was responsible for the delivery, installation, and removal of the equipment for the patients in the intervention group.
RANDOMIZATION
When the patient had signed the informed consent form, a project nurse performed the randomization. Randomization into groups was done using an automatically generated list for each block with an equal number of intervention and control numbers in random order, so as to ensure an even distribution in each group in varying sizes (10, 20, and 14) . In total, 151 cardiac patients were enrolled.
OUTCOME MEASUREMENT
Quality of life was assessed using the 36-Item Short Form Health Survey (SF-36). To estimate the changes in the number of quality-adjusted life-years (QALYs), the patients' responses to the SF-36 have been transformed using the Brazier algorithm and the SF-6D methodology. 8 This routine applies a nonparametric model to estimate SF-6D health state utility values using Bayesian methods. 9 The SF-6D comes with a set of preference weights obtained from a sample of the British population using the standard gamble method. 9 Patients who complete the questionnaires may be uniquely classified in terms of QALY values according to the SF-6D. 8 
COST MEASUREMENTS
The CUA is based on a health sector perspective. The economic evaluation follows international guidelines for conducting a CUA of a randomized controlled trial. 10 All prices and unit costs are in euros, calculated from Danish kroner (DKK) at the exchange rate of e100 = DKK 746.
11
Only direct healthcare costs are considered (i.e., costs related to the intervention [equipment, training by professionals] and to the use of healthcare [hospital admissions, ambulatory contacts, general practitioner contacts, emergency physician contacts, and other primary services]). Data on costs of the intervention, including prices of equipment used in the intervention, were obtained from companies and from worktime records of the clinical staff. Data on use of healthcare were collected for each patient from the National Patient Register and is measured in the years 2013-2014. Estimates of prices of use of inpatient and outpatient hospital care for each patient were derived from the National Patient Register and based on Diagnose Related Groups from the Danish reimbursement system.
ANALYSIS OF DATA
The statistical analysis of data is based on the intentionto-treat method. Data from the SF-36 were entered into EpiData (version 1.4.1) and transferred using EpiData Manager (version 1.3.2.1.) to a statistical package (R version. 3.1.2) for analysis. The intervention and control groups were compared using descriptive statistics and tested by t test. 
Triage Manager
The Triage Manager is a software administrative module used to administer data on the patients being monitored. The Triage Manager is provided by Tunstall Healthcare A/S and used by the healthcare professionals.
Sphygmomanometer
Approved for medical use. The meter was paired with the telehealth monitor in advance.
Digital weight scale Approved for medical use. The weight scale was paired with the telehealth monitor in advance.
ECG
The ECG is CE-approved and approved for medical use. It measures the first derived ECG scan for 40 s and then transmits the measured values to the telehealth monitor via wireless Bluetooth.
Fitbit Ultra
The Fitbit Ultra is a digital pedometer registering the number of steps. The patients with access to their data can follow their data on the telehealth monitor or at shared care. Cost is e30.83 per patient.
ActiveHeart.dk An interactive Web page with information on health, the heart, and heart diseases communicated using text and videos. The videos have instructions on exercises and short narratives by patients and relatives about their experiences with daily life after being diagnosed with heart disease. On the Web page, the patients have the possibility to call SOS International, which administers a hotline for the heart patients. 
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These tests are applied to approximately normal data as baseline characteristics and QALY measures. Data on use of resources and costs are skewed and do not follow a normal distribution. This means that the groups are compared by their means but tested using the nonparametric MannWhitney U test for differences. Statistical significance was defined at a 5% significance level. The results are presented with means for all variables included in the economic evaluation.
ETHICAL PERMISSION
The project was approved by the Danish Ethical Committee (number 20120051). The ethical principles for medical research involving human subjects, described in the Helsinki Declaration and the Act on Processing of Personal Data, were followed.
Results
Altogether, 369 patients were screened (Fig. 1) , and 151 patients were eligible and randomized. Baseline data were collected for 141 of the eligible patients (72 for the intervention group and 69 for the control group). Attrition was acceptable, as 88% of the patients completed the 6-month follow-up assessment (90% from the intervention group and 83% from the control group), and 84% completed the 12-month follow-up (89% from the intervention group and 80% from the control group). Table 3 shows the patients' characteristics at baseline. Tests of association conducted for each variable across randomization group confirmed that baseline characteristics did not differ statistically.
ESTIMATED COSTS
Data about the use of resources to carry out the intervention and the use of rehabilitation and healthcare services in the intervention and control groups is shown in Table 4 .
With regard to rehabilitation services, we found that those in the intervention group used the physiotherapist an average of 5 times and the team training an average 2.2 times; among the control group the corresponding figures were 2.9 and 3.4, respectively. However, these differences are statistically insignificant. Generally, the use of healthcare services is higher in the intervention group except for contacts to emergency doctors. However, the average number of contacts in the control group may be severely skewed due to an outlier in the control group who had 27 contacts, and the nonparametric test confirms that the difference is not significant.
The estimated mean costs per patient are presented in Table 5 . The intervention in itself costs e392 per patient, including both the costs of devices and staff resources. In the intervention group, the overall costs are for rehabilitation services about e100 higher and for healthcare services about e1,200 higher, but neither difference is statistically significant. Nevertheless, the cost of reimbursed transportation to rehabilitation is significantly higher in the control group.
The total costs of healthcare utilization are e1,200 higher on average in the intervention group, although not statistically significant. This is due mainly to the higher number of admissions. However, the total average cost per patient in the intervention group is significantly higher (e5,709) compared with the control group (e4,045), although this difference may be due to the added cost of the intervention.
ESTIMATED QALYS
The reported values in Table 6 are QALYs derived from the respondents' answers to SF-36 during the project. With an increase of 0.089 QALY in the intervention group and 0.085 QALY in the control group during the first 12 months, the difference is not significant. However, the estimated QALY show a significant increase over time in both groups.
ESTIMATED INCREMENTAL CU RATIO
The incremental cost-effectiveness ratio (ICER) is calculated according to the following formula:
where C i (i = I, C) is equal to the mean costs per patient in the two groups, where I represents the intervention group and C represents the control group. The denominator consists of the change in QALY from baseline (0 month) to the 12-month follow-up for both intervention and control groups. Based on the estimates in Tables 5 and 6, ICER can be estimated to e518,280 per QALY gained. Thus, the estimated total costs of investing in Teledialog are e518,280 per gained QALY.
Uncertainty of the estimated ICER was evaluated with probabilistic sensitivity analysis using a 5,000 bootstrap resample with a 95% bias-adjusted confidence interval (CI). The results of the resample are illustrated in the cost-effectiveness plane in Figure 2 . Based on the resample, the mean costs per patient in the intervention and control groups were estimated to be e5,724 (CI: 3,709; 953) and e4,057 (CI: 2,445; 689), respectively, and the mean QALY gain to be 0.089 (CI: 0.05; 0.13) and 0.085 (CI: 0.05; 0.12), whereas the mean ICER was e483,608.
Several sensitivity analyses were carried out to examine the robustness of the results. First, patients with very high costs (costs of more than e33,500) were excluded (4 patients). This All costs are given in euros.
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CI, confidence interval; GP, general practitioner.
reduced the difference in the mean costs per patient to e1,011. Second, fixed costs related to the investment in telemedicine devices were excluded (costs of rent of telemedicine devices, rent of the tablet computer, purchase of the Fitbit [San Francisco, CA] Ultra tracker, and establishing of the Activeheart.dk Web site) in order to estimate the marginal costs of offering the intervention to additional patients. This reduced the difference in the mean cost per patient to e1,423. Finally, the mean cost per patient was estimated, excluding the 15 patients for whom 12 months of follow-up data do not exist. This reduced the difference in the mean costs per patient to e1,023.
Discussion
The aim of the project was to develop and test an individualized CTR program to increase participation in rehabilitation, improve patient quality of life, reduce the number of admissions, and reduce use of acute care. The CUA shows that the intervention group contacted the physiotherapist more often while attending fewer group-training sessions compared with the control group, although these differences are not statistically significant. This suggests that patients in the telerehabilitation group are more likely to carry out their rehabilitation activities on an individual basis, thus supporting the main aim of the Teledialog project. Qualitative findings support that patients and healthcare professionals felt that the CTR program in Teledialog was tailored to individual needs. 12 When examining the use of healthcare in general, the number of emergency contacts to the physician by members of the intervention group is half that of the control group, whereas the numbers of re-admissions, outpatient visits, and general practitioner visits on average are higher in the intervention group, although none of these differences is statistically significant. When comparing the overall average costs across the two groups, we find that the average cost per patient is significantly higher for those in the intervention group, except for the cost for transport, which is lower in the intervention group than in the control group. We found no significant differences in the improvement of the patients' quality of life between the two groups (D = 0.004), and, taken together, these results indicate that the intervention is not costeffective, with costs per QALY gained at more than e500,000. However, it is possible that the added costs of telerehabilitation may result in other desirable outcomes that were not considered in the current study. The number of cardiac patients not participating in rehabilitation is large, and these patients could benefit from a telerehabilitation approach, although at a greater cost, which may prove to be a better outcome than nonparticipation. Widmer et al. 13 concluded, in a In addition, the continuous collection of clinically relevant data carried out using the telerehabilitation approach may provide better support to the physician in offering improved treatment recommendations, as such clinical judgments would be based on ongoing measurements compared with the more static measures obtained from one-off, face-to-face consultations.
The strengths of this study are the wide healthcare perspective, including both primary and secondary care costs. We have not identified any study where costs from the primary and secondary sectors have been included at the same time. In addition, this study has used mainly data from patient registers rather than self-reported patient data and has had a follow-up period of 1 year.
We have identified only three other CU studies of a telerehabilitation program for patients with CVD. Körtke et al. 14 presented a cost-effectiveness analysis of a nonrandomized trial of a transtelephonic guide for ambulatory rehabilitation in cardiac surgery patients. Their study showed that the total cost of the telemedicine program was lower than the conventional inhospital program. Kraal et al. 15 described a protocol for a forthcoming study of a 12-week telemonitoring-guided home-based training program. Frederix et al. 16 conducted a CUA of a 24-week comprehensive CTR program using a sample of 140 patients. The study showed that the mean cost per patient in the telemonitoring program was e564 lower than the mean costs in the control group. At the same time, the mean QALY gain per patient in the telemonitoring group was 0.026, and the conclusion therefore was that CTR tends to be more effective and efficient than centerbased CR alone. The main reason for the result was a statistically significant reduction in the number of days lost due to cardiovascular rehospitalizations in the intervention group. The Teledialog study has several limitations. First, the project was a small-scale research project. Only healthcare costs were included in the estimation, and potential savings for the patient (e.g., savings due to a lower degree of use of pharmaceuticals) and for the municipality related to the possible improvement in the patients' quality of life were not taken into account. Using a higher number of patients may thus result in reduced costs of the devices used in the intervention and make the CTR program more cost-effective over the long term.
Second, we found an unexpected difference in the costs of outpatient and inpatient visits. Only hospital visits related to heart disease are included in the study, and based on the estimated low impact on the patients' quality of life, no difference in these costs was to be expected. Therefore, only a few patients with high healthcare costs unrelated to the degree of rehabilitation may have had a large impact on the costs. As a consequence, larger studies are needed to provide further examination of the differences in costs per patient.
Third, the measure of the patients' quality of life, the Brazier algorithm, and the SF-6D methodology may be criticized for being too generic and not sensitive enough for identifying the changes in the patient's health related to rehabilitation.
Conclusions
The current study shows that an individualized CTR program may increase the patient's participation in rehabilitation activities, reduce the cost of transport, and reduce the number of emergency physician visits. However, the mean total healthcare cost per patient in the intervention group was significantly higher, and improvement in the patients' quality of life was not significant, compared with the costs and quality of life of the patients in the control group. Taken together, these findings indicate that the telerehabilitation approach is not costeffective in a small-scale study. It is possible that increasing the number of patients in the sample may show reduced costs of the devices and make the telerehabilitation program more costeffective. In addition, increasing rehabilitation participation and perhaps the kind of clinically relevant data collected may give the telerehabilitation approach an additional advantage. More research is needed to identify the potential for the use of telerehabilitation for cardiac patients.
